23andMe receives new FDA green light

23andMe (ME) rises on FDA clearance to report more genetic variants. (00:26) UPS offers some pilots an early retirement package. (01:12) Bernstein says reclassifying cannabis as Schedule III not preferred outcome. (01:47)Episode transcripts seekingalpha.com/wsb.Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.Show links:Fresh stimulus from China to bolster crisis-hit property sectorAditxt stock drops 48% on $10M private placementLi Auto sales rose 663.8% Y/Y in AugustFord Motor offers UAW workers a 15% combined wage raise